HK1068003A1 - Pharmaceutical composition comprising gamma-butyrobetaine - Google Patents

Pharmaceutical composition comprising gamma-butyrobetaine

Info

Publication number
HK1068003A1
HK1068003A1 HK05100218A HK05100218A HK1068003A1 HK 1068003 A1 HK1068003 A1 HK 1068003A1 HK 05100218 A HK05100218 A HK 05100218A HK 05100218 A HK05100218 A HK 05100218A HK 1068003 A1 HK1068003 A1 HK 1068003A1
Authority
HK
Hong Kong
Prior art keywords
butyrobetaine
gamma
disclosed
erection
pharmaceutical compositions
Prior art date
Application number
HK05100218A
Other languages
English (en)
Inventor
Ivars Kalvinsh
Maris Veveris
Anatolijs Birmans
Original Assignee
Ivars Kalvinsh
Maris Veveris
Anatolijs Birmans
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ivars Kalvinsh, Maris Veveris, Anatolijs Birmans filed Critical Ivars Kalvinsh
Publication of HK1068003A1 publication Critical patent/HK1068003A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK05100218A 2001-09-07 2005-01-11 Pharmaceutical composition comprising gamma-butyrobetaine HK1068003A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LVP-01-134A LV12979B (en) 2001-09-07 2001-09-07 Pharmaceutical composition
PCT/LV2002/000004 WO2003022262A1 (en) 2001-09-07 2002-03-04 Pharmaceutical composition comprising gamma-butyrobetaine

Publications (1)

Publication Number Publication Date
HK1068003A1 true HK1068003A1 (en) 2005-04-22

Family

ID=19735292

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05100218A HK1068003A1 (en) 2001-09-07 2005-01-11 Pharmaceutical composition comprising gamma-butyrobetaine

Country Status (30)

Country Link
US (1) US20040242590A1 (xx)
EP (1) EP1429753B1 (xx)
JP (1) JP4382480B2 (xx)
KR (1) KR100841035B1 (xx)
CN (1) CN1275595C (xx)
AR (1) AR036423A1 (xx)
AT (1) ATE350029T1 (xx)
AU (1) AU2002236340B2 (xx)
BG (1) BG108673A (xx)
CA (1) CA2459719C (xx)
CU (1) CU23347B6 (xx)
DE (1) DE60217369T2 (xx)
DK (1) DK1429753T3 (xx)
EA (1) EA006675B1 (xx)
ES (1) ES2280505T3 (xx)
HK (1) HK1068003A1 (xx)
HR (1) HRPK20040328B3 (xx)
IL (2) IL160734A0 (xx)
JO (1) JO2507B1 (xx)
LV (1) LV12979B (xx)
MA (1) MA27683A1 (xx)
MX (1) MXPA04002050A (xx)
MY (1) MY134074A (xx)
NZ (1) NZ532178A (xx)
PL (1) PL368758A1 (xx)
PT (1) PT1429753E (xx)
SI (1) SI1429753T1 (xx)
TW (1) TWI224506B (xx)
WO (1) WO2003022262A1 (xx)
ZA (1) ZA200402702B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10325813B4 (de) * 2003-06-06 2007-12-20 Universitätsklinikum Freiburg Prophylaxe und/oder Therapie bei der portalen Hypertonie
LV13450B (en) * 2004-08-24 2006-11-20 Grindeks As Novel medicinal use of meldonium and pharmaceutical compositions thereof
EP1909576A4 (en) 2005-07-29 2010-09-01 Concert Pharmaceuticals Inc NEW PHARMACEUTICAL COMPOUNDS
WO2009095445A1 (en) * 2008-01-29 2009-08-06 Grindeks New second medical use of 3-(2,2,2-trimethylhydrazine)propionate dihydrate
CN101781302B (zh) * 2009-05-31 2013-07-10 段波 一种磷酸二酯酶抑制剂和异黄酮形成的加成物及其应用
RU2622757C1 (ru) * 2016-06-02 2017-06-19 федеральное государственное автономное образовательное учреждение высшего образования Первый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский университет) Способ лечения эректильной дисфункции

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1198434B (it) * 1981-01-06 1988-12-21 Sigma Tau Ind Farmaceuti Composizione farmaceutica comprendente gamma butirrobetaina per il trattamento di sindromi da carenze di carnitina
LV11728B (en) * 1995-08-21 1997-08-20 Kalvins Ivars Pharmaceutical composition
LV11727B (en) * 1995-08-21 1997-08-20 Kalvins Ivars Pharmaceutical composition

Also Published As

Publication number Publication date
MA27683A1 (fr) 2006-01-02
JP4382480B2 (ja) 2009-12-16
HRPK20040328B3 (en) 2006-02-28
DK1429753T3 (da) 2007-05-14
DE60217369T2 (de) 2007-08-23
CA2459719C (en) 2010-07-06
HRP20040328A2 (en) 2004-08-31
AR036423A1 (es) 2004-09-08
CU23347B6 (es) 2009-02-20
BG108673A (en) 2005-03-31
MXPA04002050A (es) 2004-06-07
US20040242590A1 (en) 2004-12-02
EA006675B1 (ru) 2006-02-24
JP2005504071A (ja) 2005-02-10
EP1429753A1 (en) 2004-06-23
PL368758A1 (en) 2005-04-04
MY134074A (en) 2007-11-30
AU2002236340B2 (en) 2008-06-12
WO2003022262A1 (en) 2003-03-20
CN1551764A (zh) 2004-12-01
PT1429753E (pt) 2007-04-30
NZ532178A (en) 2007-05-31
KR20040034704A (ko) 2004-04-28
CA2459719A1 (en) 2003-03-20
ATE350029T1 (de) 2007-01-15
ZA200402702B (en) 2005-05-11
IL160734A (en) 2009-09-22
EA200400386A1 (ru) 2004-08-26
ES2280505T3 (es) 2007-09-16
IL160734A0 (en) 2004-08-31
TWI224506B (en) 2004-12-01
CN1275595C (zh) 2006-09-20
DE60217369D1 (de) 2007-02-15
EP1429753B1 (en) 2007-01-03
KR100841035B1 (ko) 2008-06-24
SI1429753T1 (sl) 2007-06-30
JO2507B1 (en) 2009-10-05
LV12979B (en) 2003-05-20

Similar Documents

Publication Publication Date Title
SG153830A1 (en) Galenic formulations of organic compounds
MXPA03005464A (es) Agentes antivirales.
YU69902A (sh) Novi derivati piperazina
WO2003000343A3 (en) Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation
LU91079I2 (fr) Tramacet et ses dérivés pharmaceutiquement acceptables.
MA26861A1 (fr) Inhibiteurs non peptidiques de la liaison cellulaire sous la dependance de vla-4 utiles dans le traitement des maladies inflammatoires, auto-immunes et respiratoires
AU2003225617A1 (en) Thiadiazolylpiperazine derivatives useful for treating or preventing pain
HK1068003A1 (en) Pharmaceutical composition comprising gamma-butyrobetaine
WO2000045801A3 (en) Use of a nitrate vasodilator alone or in combination with capsaicin for the treatment of pain
EE200100619A (et) Asendatud bensimidasoolid, nende saamine ning kasutamine ravimi valmistamiseks, mis on ette nähtud NFkB aktiivsuse suurenemisest tingitud haiguste profülaktikaks ja raviks
EA200400007A1 (ru) ФАРМАЦЕВТИЧЕСКИЙ СОСТАВ ДЛЯ ЭФФЕКТИВНОГО ВВЕДЕНИЯ АПОМОРФИНА, 6aR-(-)-N-ПРОПИЛ-НОРАПОМОРФИНА, ИХ ПРОИЗВОДНЫХ И ИХ ПРОЛЕКАРСТВ
WO2005014617A3 (en) Cyclic peptide compositions and methods for treatment of sexual dysfunction
EE200200107A (et) Kiire algtoimega selektiivse serotoniini tagasihaaramise inhibiitori kasutamine ravimi valmistamiseks, mis on ette nähtud seksuaalse funktsioonihäireravimiseks
EP0992240A4 (en) THERAPEUTIC AGENT FOR TREATING ANERECTION
PL356237A1 (en) Pyrimidine derivatives as selective inhibitors of cox-2
SE9802206D0 (sv) Novel compounds
HUP0300615A2 (hu) Sibutramint és orlistatot tartalmazó gyógyszerkészítmény
MX9700245A (es) Nuevo compuesto quimico, su preparacion y su empleo como medicamento.
NO20013414D0 (no) Ny anvendelse av melagatran
SE0004101D0 (sv) New use
UA37278C2 (uk) Протикашльова фармацевтична композиція для перорального введення
WO1999065475A3 (en) Combination of phentolamine and apomorphine for the treatment of human sexual function and dysfunction
WO2002024661A3 (en) New n, n'-disubstituted benzimidazolone derivatives with affinity at the serotonin and dopamine receptors
WO2004010924A3 (en) Pyrroloquinoline quinone drugs as a neuroprotectant and methods of use thereof
EP1616862A4 (en) HETEROCYCLIC NITROGEN COMPOUND AND USE THEREOF

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20150304